ARTICLE | Company News
Kinetek, QLT deal
June 11, 2001 7:00 AM UTC
QLT and Kinetek will develop signal transduction inhibitors to treat ophthalmic, immune system and kidney diseases. QLT invested C$11 million (US$7.2 million) in Kinetek to support the discovery and v...